                         SEQUENCE LISTING

<110>  F. Hoffmann-La Roche AG
       Roche Diagnostics GmbH
       Roche Molecular Systems, Inc.
 
<120>  DETECTION OF TARGET NUCLEIC ACID BY SOLID-PHASE MOLOGRAPHY

<130>  P34923-WO-HS

<150>  62/782,867
<151>  2018-12-20

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  49
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HIV-1 LTR tag 3 probe

<400>  1
cacacattgg caccgccgtc ttctctagca gtggcgcccg aacagggac                   49


<210>  2
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Moligo tag 3 oligonucleotide

<400>  2
tttttttttt ttagagaaga cggcggtgcc aatgtgtg                               38


<210>  3
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  AT-MOLO-3 oligonucleotide

<400>  3
cacacattgg caccgccgtc tt                                                22


<210>  4
<211>  100
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  HIV-LTR-moligo-100 oligonucleotide

<400>  4
ttgcatgaga atagtaacgt attgtgtaaa gcaggatata gagtaattgc ccagttgttc       60

caaatcgata ttgcagagaa gacggcggtg ccaatgtgtg                            100


